Navigation Links
Herceptin + Hormonal Therapy Pack Reduces Breast Cancer Progression

In a new study, Roche Holding AG (RHHBY), a Swiss pharmaceutical company says, breast cancer progression decreases when Herceptin was added to hormonal therapy//. When the patient condition is hormone receptor-positive, as well as HER2-positive, this combined therapy proves to be progression-free. Hormone receptor-positive breast cancer results lower risk rate whereas HER2-positive breast cancer aggressive form of the disease that requires special and immediate attention due to fast- developing tumour.

Eduard Holdener, Global Head of Roche Pharma Development reported that a combination therapy proved a new better treatment for breast cancer patients, who suffer from an extremely aggressive form of the disease. AII over the world nearly above 230,000 patients with HER2-positive breast cancer are trailed for treatment with Herceptin. And whether used alone or with other combination of therapies Herceptin consistently benefits patients.

Across the world, in 25 countries about 208 HER2 and hormone receptor co-positive patients were enrolled at 134 sites.The randomised, Phase III trial, conducted by Roche started in 2001 which evaluated Herceptin plus Arimidex versus Armidex alone as first-line therapy -or second line hormonal therapy- in postmenopausal women with advanced, HER2-positive and hormone receptor-positive breast cancer -TAnDEM study reports.

Arimidex - a dose of 1 mg daily and Herceptin a dose of 2 mg/kg weekly were given after an initial loading dose of 4 mg/kg, until disease progression. At the end, patients who received Herceptin had a statistically significant improvement in progression-free survival.

Overall safety data and side-effects were continued to be followed.


'"/>




Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Drug Herceptin To Be Recommended To All Breast Cancer Patients
3. Herceptin Is A Possible Cure For Breast Cancer
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
6. Wangaratta Community fundraising for Herceptin drug
7. Herceptin for Early Stage Breast cancer
8. Treatment of Breast Cancer with Herceptin for Nine Weeks
9. Herceptin is the cure for early stages of breast cancer?
10. 10-year-old Pleads, Herceptin For My Mum, Please
11. Norfolk PCTs To Offer Herceptin
Post Your Comments:
(Date:12/21/2014)... December 21, 2014 Serious Buyer, Andrew ... 1967 Jm Morrison and the Doors International Ballroom at ... would also be the only time that Morrison's mother ... on Nov. 25, 1967. According to Hawley, “This would ... did play the Alexandria Roller Rink earlier that year ...
(Date:12/21/2014)... Columbus, OH (PRWEB) December 21, 2014 ... of men alleging heart attacks, stroke and blood clots ... continue to increase, a new study shows that the ... developing colon cancer. In a study published in the ... lead researcher, James Amos-Landgraf examined a group of male ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is ... the business has announced its bamboo flooring promotion ... best material from certified suppliers, and offers the ... worldwide. In the current promotion, all customers can ... when they say they know BambooIndustry.com from press ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... ) that allege a metal-on-metal version of the ... move forward in state and federal courts, Bernstein ... in New Jersey’ Bergen County Superior Court on ... were permitted to begin deposition of plaintiffs on ...
(Date:12/20/2014)... 20, 2014 Angeldress.co.uk, the distinguished wedding ... for worldwide dress fans. The company has recently updated ... information. For the holiday season, Angeldress Blog ... wedding apparel. , Angeldress.co.uk prides itself in offering a ... of service. All the company’s outfits are very carefully ...
Breaking Medicine News(10 mins):Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:Trendy Professional Wedding Apparel Recommended by Angeldress Blog 2
... Oct. 24 (HealthDay News) -- Roughly 10 percent of Americans ... that doing so increases their risk for three common skin ... In conducting the study, researchers tracked the tanning bed ... high school and college, and then when the women were ...
... team led by scientists from The University of Texas MD ... their quest to map the vast blood vessel network of ... of Oct. 24 in the Proceedings of the National ... the goal of using the vascular system to personalize cancer ...
... Furlong founded Parent Project Muscular Dystrophy (PPMD) in 1995 to ... dystrophy with both resources and hope. Now, Furlong has blazed ... She has spearheaded a partnership between PPMD and the Public ... Currents: Muscular Dystrophy, this month. The story of the partnership ...
... Jenifer Goodwin HealthDay Reporter , MONDAY, Oct. 24 ... the airways of children with autism that she says may ... While examining children with autism who came in for a ... can see down into the windpipe and the airways that ...
... related macular degeneration (AMD) is the leading cause of ... identified several relatively common genetic variants which together predict ... number of persons without the disease also have these ... able to clearly show a specific rare mutation called ...
... University,s Office of Intellectual Property and Commercialization and ... institution,s faculty and researchers for technologies they have ... inventors. Faculty recognized for these achievements represent ... of Applied and Natural Sciences, College of Liberal ...
Cached Medicine News:Health News:More Evidence Links Tanning Beds to Higher Skin Cancer Risk 2Health News:Blood vessel mapping reveals 4 new 'ZIP codes' 2Health News:Blood vessel mapping reveals 4 new 'ZIP codes' 3Health News:Patient advocacy groups turn to open-access publishing to advance research quest 2Health News:Could Airway Abnormality Point to Autism? 2Health News:Could Airway Abnormality Point to Autism? 3Health News:Researchers ID genetic mutation associated with high risk of age-related macular degeneration 2Health News:Louisiana Tech University recognizes innovators, inventors 2Health News:Louisiana Tech University recognizes innovators, inventors 3
(Date:12/19/2014)... INDIANAPOLIS and LYON, France ... (NYSE: LLY ) and Adocia (Euronext Paris: ... focused on developing an ultra-rapid insulin, known as BioChaperone ... type 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary ... Lilly and Adocia will develop BioChaperone Lispro ...
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... Corporation (NASDAQ: VOLC ), a global leader in ... that they have entered into a definitive merger agreement. Pursuant ... acquire all of the issued and outstanding shares of Volcano ... price of USD 1 billion (approx. EUR 800 million), to ...
(Date:12/17/2014)... -- Revenue and earnings above the previous year ... In the past 2013/14 fiscal year (ended 30 ... EUR 4.287 billion (last year: EUR 4.190 billion) despite unfavorable ... 360 million. "Overall, 2013/14 was a successful fiscal year for ... and CEO of Carl Zeiss AG. "Thanks to our broad ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8ZEISS Asserts its Position in Difficult Environment 2
... May 21, 2007/PRNewswire-FirstCall/ -- Bristol-Myers,Squibb Company (NYSE: ... which showed that treatment with Baraclude (entecavir),demonstrated ... 48 weeks,-- a result that was also ... These data from an open-label, randomized viral ...
... -- Data presented,today at a major medical meeting ... for five days is as,effective as standard therapy ... treatment of complicated urinary tract infections,(cUTI) and acute ... markets LEVAQUIN in the,U.S., presented the data during ...
Cached Medicine Technology:Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 2Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 3Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 4Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 5Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load,Reduction Compared to Adefovir at 48 Weeks in Study of,Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients 6Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 2Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 3Five Days of LEVAQUIN(R) as Effective as 10 Days of Ciprofloxacin,in Complicated Urinary Tract Infections and Acute Pyelonephritis 4
... to facilitate an arthrodesis, either by an ... cages allowing radicular compression by restoring the ... of the foramina, which in turn enhances ... major lumbar instabilities.,CC cages are made of ...
... The PACHETT 3 uses the exact enhanced ... the DGH pachymeters used exclusively by the ... built into the software. The new backlit ... running average, standard deviation and IOP correction ...
... Already, the most advanced motor driven ... easier and faster to learn and operate. ... maintaining accuracy and precision. Our software makes ... easy transition from manual instruments or other ...
The Medmont C100 Colour Vision Tester is an electronic colour vision screening device which is used to rapidly detect red/green colour vision deficiencies. Its high sensitivity provides a positive in...
Medicine Products: